Results 201 to 210 of about 161,532 (251)

Risk Factors for Secondary Immunodeficiency in the Aged. [PDF]

J Allergy Clin Immunol Pract
Lang A, Grammatikos A, Ballow M, Otani I, Barmettler S.   +4 more
europepmc   +1 more source

Cancer vaccines: comprehensive review. [PDF]

BJS Open
Clifford RE, Manu N, Yang Q, Arif Z, Aggen D, Bryan ME, Gupta A, Shaw H, Church D, Corrie P, Savelyeva N, Ottensmeier C, Danson S, Jones R.   +13 more
europepmc   +1 more source

‌An mRNA vaccine confers enhanced protection against herpes simplex virus through an IFN-I-dependent pathway. [PDF]

NPJ Vaccines
Zhao W, Sun L, Wang P, Zhao Q, Li Y, Li Y, Shi H, Xing M, Dai W, Zhou D.   +9 more
europepmc   +1 more source

Harnessing <i>Toxoplasma gondii</i> microneme proteins for serodiagnosis and vaccine development: a review. [PDF]

Ann Med
Ji Y, Wang Z, Feng Y, Ahmad I, Alzahrani KJ, Alsharif KF, Alzahrani FM, Zhao X, Qadeer A, Liu W.   +9 more
europepmc   +1 more source

<i>Leptospira</i> Infections in Cats-What Do We Know? [PDF]

Pathogens
Wasiński B.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

DNA vaccines

Seminars in Immunology, 1997
DNA vaccines use eukaryotic expression vectors to produce immunizing proteins in the vaccinated host. Popular methods of delivery are intramuscular and intradermal saline injections of DNA and gene gun bombardment of skin with DNA-coated gold beads.
Robinson, Harriet L., Torres, Celia Aurora Tiglao   +1 more
  +11 more sources

DNA Vaccines

AIDS Research and Human Retroviruses, 1996
Immunization with plasmid DNA encoding antigenic proteins elicits both antibody and cell-mediated immune responses. This method of producing the protein antigens of interest directly in host cells can provide appropriate tertiary structure for the induction of conformationally specific antibodies, and also facilitates the induction of cellular immune ...
Robinson, Harriet L., Lu, Shan, Feltquate, David Marc, Torres, Celia Aurora Tiglao, Richmond, Joann M., Boyle, Christine Margaret, Morin, Merribeth J., Santoro, Joseph C., Webster, Robert G., Montefiori, David C., Yasutomi, Yasuhiro, Letvin, Norman L., Manson, Kelledy, Wyand, Michael, Haynes, Joel R.   +14 more
  +11 more sources

HPV DNA vaccines

Frontiers in Bioscience, 2003
Human papillomaviruses (HPV), particularly HPV type 16, are the primary etiologic agent of cervical cancer. Thus, HPV-associated cervical malignancies might be prevented or treated by induction of the appropriate virus-specific immune responses in patients.
Michelle, Moniz, Morris, Ling, Chien-Fu, Hung, T-C, Wu   +3 more
openaire   +2 more sources

DNA vaccines for biodefence

Advanced Drug Delivery Reviews, 2005
The advantages associated with DNA vaccines include the speed with which they may be constructed and produced at large-scale, the ability to produce a broad spectrum of immune responses, and the ability for delivery using non-invasive means. In addition, DNA vaccines may be manipulated to express multiple antigens and may be tailored for the induction ...
Helen S, Garmory, Stuart D, Perkins, Robert J, Phillpotts, Richard W, Titball   +3 more
openaire   +2 more sources

DNA vaccination in the avian

Veterinary Immunology and Immunopathology, 2002
Inoculation of naked DNA represents a novel approach to vaccine and immune therapeutic development. DNA vaccines or genetic immunization offers several advantages over the conventional vaccines for specific immune activation. Although a large number of vaccines have been made and are being used in the poultry industry, there have been no major advances
G L, Oshop, S, Elankumaran, R A, Heckert
openaire   +2 more sources